Tag: biomedical
-
Commercial Data Yield Genetic Links to Depression
An analysis of data from commercial genetic tests identified 15 regions in the genome and 17 specific variations associated with depression among people of European descent.
-
Trial to Assess Anti-Gravity Treadmill for Stress Test
Researchers at University of Cincinnati Medical Center plan to evaluate an anti-gravity treadmill for cardiac stress tests that check for heart disease.
-
GSK, Alphabet Form Bioelectronic Device Venture
Drug maker GlaxoSmithKline, or GSK, and Verily Life Sciences, a division of Alphabet, the parent company of Google, are forming a joint venture to develop miniaturized therapeutic electronic devices.
-
Portable On-Demand Biologic Production System Designed
A device that produces small batches of biological drugs, down to a single dose, was shown to generate two different biopharmaceuticals under lab conditions.
-
Open-Source Discovery Yields Anti-Malaria Candidates
A worldwide research project tested 400 compounds as anti-malarial drugs, which led to more than 30 new drug development programs for malaria and other diseases.
-
Gene Therapy Designed for Muscle Wasting Disease
Researchers devised a treatment for a cancer-related muscle wasting disease using gene transfers that in lab mice block signals promoting muscle degradation.
-
Trial Underway Testing Stem Cells to Treat Alzheimer’s
An intermediate-stage clinical trial is recruiting participants to test donated stem cells as a treatment for mild-moderate dementia from Alzheimer’s disease.
-
Nanoparticles, Peroxide Boost Tooth Decay Prevention
Adding iron oxide nanoparticles to hydrogen peroxide is shown to reduce the build-up of bacterial films on teeth, preventing cavities from forming in lab rats.
-
Patch Delivers Gene, Drug, Heat Therapies to Colon Tumors
Engineers developed a hydrogel patch with three types of therapy applied directly to tumors in the colon, which in lab mice caused cancer to go into remission.
-
Trial Shows 5-Year Retinal Implant Safety, Efficacy
A device implanted people with retinitis pigmentosa shows after 5 years the device provides visual function to recipients, largely without adverse effects.